Further Evidence of Varying Risks and Benefits of Different Inhaled Corticosteroid/Long-acting Beta-agonist Combinations in COPD
- PMID: 32386630
- DOI: 10.1016/j.chest.2020.01.009
Further Evidence of Varying Risks and Benefits of Different Inhaled Corticosteroid/Long-acting Beta-agonist Combinations in COPD
Comment on
-
Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD.Chest. 2020 May;157(5):1117-1129. doi: 10.1016/j.chest.2019.12.006. Epub 2019 Dec 28. Chest. 2020. PMID: 31887282
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
